The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 04, 2025

Filed:

Jun. 27, 2019
Applicant:

Meiji Seika Pharma Co., Ltd., Tokyo, JP;

Inventors:

Natsuki Ishida, Yokohama, JP;

Yuji Tabata, Yokohama, JP;

Takashi Matsuhira, Yokohama, JP;

Keiji Tamura, Yokohama, JP;

Takeru Yamakawa, Tokyo, JP;

Satoshi Isshiki, Odawara, JP;

Yoshinari Wakiyama, Odawara, JP;

Shohei Ouchi, Yokohama, JP;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4995 (2006.01); A61K 31/439 (2006.01); A61K 31/5386 (2006.01); A61P 17/04 (2006.01); A61P 19/02 (2006.01); A61P 19/04 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01); A61P 37/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4995 (2013.01); A61K 31/439 (2013.01); A61K 31/5386 (2013.01); A61P 17/04 (2018.01); A61P 19/02 (2018.01); A61P 19/04 (2018.01); A61P 29/00 (2018.01); A61P 35/00 (2018.01); A61P 35/02 (2018.01); A61P 37/06 (2018.01);
Abstract

A therapeutic agent for treating at least one disease selected from the group consisting of inflammatory diseases, autoimmune diseases, fibrotic diseases, and cancer diseases, comprising: at least one selected from the group consisting of a compound represented by the following general formula (1) and pharmacologically acceptable salts thereof as an active ingredient. [In the formula (1),


Find Patent Forward Citations

Loading…